Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Duke University
- Study ID
- NCT06986304
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The project will include 30 patients with bladder cancer who are candidates for bladder removal. After signing the consent form, the study team will collect some clinical data, such as age, past medical history, past surgical history, and information about your current disease. At the day of surgery, after putting participants into sleep and before surgery begins, the study team will do a novel ultrasound called "Super-Resolution Ultrasound Localization Microscopy" to check if there is still disease in the bladder. The team will then compare the results of this investigational ultrasound with the final pathology and other imaging studies.
Key Dates
- Start date
- Oct 28, 2025
- Status verified
- Apr 2026
- Primary completion
- Jan 31, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 30 participants (estimated)
Primary Outcome Measure
Presence and stage of residual bladder cancer at the time of RC. [ Time Frame: From enrollment to first post-cystectomy follow-up visit (1 month) ]
Central Contacts
- Michael Abern, M.D.919-684-5057
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke University | Durham | North Carolina | 27710 | Alireza Ghoreifinejadian, M.D. 919-684-8111 Michael Abern, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Durham, NC
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the BladderPHASE1/PHASE2 · Recruiting · Noah Hahn, M.D. · Phoenix, Arizona
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPHASE1 · Recruiting · Clasp Therapeutics, Inc. · Scottsdale, Arizona